Loss of TapA disrupts division, dysregulates pole formation, and sensitizes Mycobacterium tuberculosis and other mycobacteria to several first and second-line TB antibiotics, establishing TapA as a potential therapeutic target, and defining a new link between cell cycle progression, envelope remodeling, and intrinsic antibiotic resistance in mycobacteria. Here, TAPBP is linked to tuberculosis.